WILSON JAMES N sold $1.1M of CORT (indirect holdings)
WILSON JAMES N sold 10,000 indirectly-held shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $110.69 ($110.27–$111.70, $1.11M total) across 3 trades on 2026-09-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides a data point for investors monitoring insider activity.
Market read
Insider sale of $1.1M by a director is a modest negative signal but unlikely to move the stock significantly.
What to watch
Potential upcoming clinical data or partnership announcements could offset the sale impact.
Background
Form 4 filing discloses insider transactions required by SEC regulations.
Ticker impact
Director Wilson James sold 10,000 shares for $1.1M via a 10b5-1 plan on 2026-09-15.
Slight short-term dip expected, limited to a few basis points.
Insider sale by a director signals possible concerns, but size relative to float is modest.
Market effects
Minimal impact on the biotech sector; typical insider sale.
None beyond the company's own stock.
Not applicable.
Counterpoint
The sale may be routine liquidity planning; price could hold or rise on fundamentals.
Key entities
- CompanyCorcept Therapeutics Inc.
Biopharmaceutical company developing cortisol‑receptor antagonists.
- PersonWilson James N.
Director of Corcept Therapeutics.
